首页 | 本学科首页   官方微博 | 高级检索  
检索        

蓝萼甲素对三阴性乳腺癌MDA-MB-231细胞增殖及细胞周期的影响
引用本文:鲍刚,吴沁航,高芙蓉,潘扬,王小龙.蓝萼甲素对三阴性乳腺癌MDA-MB-231细胞增殖及细胞周期的影响[J].中草药,2019,50(6):1419-1423.
作者姓名:鲍刚  吴沁航  高芙蓉  潘扬  王小龙
作者单位:南京中医药大学药学院, 江苏 南京 210023,南京中医药大学药学院, 江苏 南京 210023,南京中医药大学药学院, 江苏 南京 210023,南京中医药大学药学院, 江苏 南京 210023,南京中医药大学药学院, 江苏 南京 210023
基金项目:江苏高校优势学科建设工程资助项目(PAPD);江苏省高校自然科学面上项目(16KJB150033)
摘    要:目的研究蓝萼甲素对三阴性乳腺癌MDA-MB-231细胞增殖及细胞周期的影响及其作用机制。方法采用MTT法检测蓝萼甲素对MDA-MB-231细胞增殖的影响;流式细胞仪检测细胞周期;Western blotting法检测细胞中cyclin B1、cyclin D1、细胞周期素依赖激酶2(CDK2)、CDK4、p53、p21、p27、组蛋白赖氨酸特异性去甲基化酶1(LSD1)、组蛋白H3第4位赖氨酸二甲基化(H3K4me2)、组蛋白H3第9位赖氨酸二甲基化(H3K9me2)蛋白表达水平。结果蓝萼甲素能显著抑制MDA-MB-231细胞的增殖,呈剂量和时间依赖性;提高G2/M期细胞比例;上调p53、p21、p27、H3K4me2、H3K9me2蛋白表达水平,下调cyclin B1、cyclin D1、CDK2、CDK4、LSD1蛋白表达水平。结论蓝萼甲素抑制MDA-MB-231细胞增殖,阻滞MDA-MB-231细胞周期于G2/M期,其机制可能与激活p53的表达及调控组蛋白的甲基化作用有关。

关 键 词:蓝萼甲素  三阴性乳腺癌  MDA-MB-231细胞  细胞周期  p53  组蛋白赖氨酸特异性去甲基化酶1
收稿时间:2019/1/3 0:00:00

Effect of glaucocalyxin A on proliferation and cell cycle of triple-negative breast cancer MDA-MB-231 cells
BAO Gang,WU Qin-hang,GAO Fu-rong,PAN Yang and WANG Xiao-long.Effect of glaucocalyxin A on proliferation and cell cycle of triple-negative breast cancer MDA-MB-231 cells[J].Chinese Traditional and Herbal Drugs,2019,50(6):1419-1423.
Authors:BAO Gang  WU Qin-hang  GAO Fu-rong  PAN Yang and WANG Xiao-long
Institution:School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China,School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China,School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China,School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China and School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
Abstract:Objective To investigate the effect of glaucocalyxin A on proliferation and cell cycle of triple-negative breast cancer MDA-MB-231 cells and its mechanism. Methods The proliferation inhibition rates of MDA-MB-231 cells were measured by MTT assay. The cell cycle was analyzed by flow cytometry, and the expression of the protein cyclin B1, cyclin D1, CDK2, CDK4, p53, p21, p27, LSD1, H3K4me2, and H3K9me2 was detected by Western blotting. Results Growth of MDA-MB-231 cells was significantly inhibited by glaucocalyxin A in a dose-dependent and time-dependent manner. Flow cytometric analysis indicated that the percentage of MDA-MB-231 cells at G2/M phase was increased significantly. As the results of Western blotting, the protein expression levels of p53, p21, p27, H3K4me2, and H3K9me2 in MDA-MB-231 cells were increased, while that of cyclin B1, cyclin D1, CDK2, CDK4, and LSD1 were decreased after treated with glaucocalyxin A. Conclusion Glaucocalyxin A could inhibit the proliferation of MDA-MB-231 cells and induce cell cycle arrest at the G2/M phase, and the mechanism may be related to the activation of p53 protein expression and the regulation of histone methylation.
Keywords:glaucocalyxin A  triple-negative breast cancer  MDA-MB-231 cells  cell cycle  p53  LSD1
本文献已被 CNKI 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号